/Purpose: Peripheral capillary oxygen saturation (SpO 2 ) is used as surrogate for arterial blood oxygen saturation. We studied the degree of discrepancy between SpO 2 and arterial oxygen (SaO 2 ) and identified parameters that may explain this difference. Methods: We included patients who underwent cardiopulmonary exercise testing at Cleveland Clinic. Pulse oximeters with forehead probes measured SpO 2 and arterial blood gas samples provided the SaO 2 both at rest and peak exercise. Results: We included 751 patients, 54 T 16 yr old with 53% of female gender. Bland-Altman analysis revealed a bias of 3.8% with limits of agreement of 0.3% to 7.9% between SpO 2 and SaO 2 at rest. A total of 174 (23%) patients had SpO 2 Q 5% of SaO 2 , and these individuals were older, current smokers with lower forced expiratory volume in the first second and higher partial pressure of carbon dioxide and carboxyhemoglobin. At peak exercise (n = 631), 75 (12%) SpO 2 values were lower than the SaO 2 determinations reflecting difficulties in the SpO 2 measurement in some patients. The bias between SpO 2 and SaO 2 was 2.6% with limits of agreement between j2.9% and 8.1%. Values of SpO 2 Q 5% of SaO 2 (n = 78, 12%) were associated with the significant resting variables plus lower heart rate , oxygen consumption, and oxygen pulse. In multivariate analyses, carboxyhemoglobin remained significantly associated with the difference between SpO 2 and SaO 2 both at rest and peak exercise. Conclusions: In the present study, pulse oximetry commonly overestimated the SaO 2 . Increased carboxyhemoglobin levels are independently associated with the difference between SpO 2 and SaO 2 , a finding particularly relevant in smokers.
P eripheral capillary oxygen saturation (SpO 2 ) is commonly measured by pulse oximetry, which provides an indirect measurement of arterial oxygenation (SaO 2 ) based on the differential absorption of light by oxygenated and deoxygenated blood during pulsatile blood flow (1) . Pulse oximetry offers a noninvasive and rapid determination of SaO 2 , particularly when the SaO 2 is above 75% (2) . Arterial blood gas (ABG) analysis provides a direct measurement of the arterial partial pressure of oxygen (PaO 2 ) and SaO 2 among other important parameters that are used to assess ventilation and acid base status. However, ABG analysis requires more time and expense as well as an arterial puncture (3). Thus, SpO 2 is routinely used as surrogate for SaO 2 .
Precision and accuracy of SpO 2 readings can be affected by technical problems inherent to the measuring device or inadequate interpretation of the data (4) . Some sources of error can be modified (i.e., improper probe placement, motion artifact, nail polish, and stray light), whereas others cannot (i.e., presence of carboxyhemoglobin, methemoglobin, and skin pigmentation). In cases of poor perfusion, the accuracy of the reading can be optimized by changing the probe to a different location (e.g., finger, ear lobe or forehead), applying heat or a vasodilator cream, placing the hand below the level of the heart, or trying a different sensor or pulse oximeter (4, 5) .
A good agreement between SpO 2 and the reference method of ABG analysis has been reported by some authors (6) , whereas others reported an overestimation or underestimation of the SaO 2 (7) (8) (9) . Some studies have pointed out that SpO 2 may not always be a reliable method to predict SaO 2 (10, 11) . High venous pressure states can falsely lower SpO 2 values (3, 12) . Furthermore, decreased accuracy of SpO 2 has been described in hypoxemic (7) , hemodynamically compromised (8, 9) , and critically ill (13) patients, in whom an accurate and reliable monitoring is of major importance. Increases in carboxyhemoglobin and on certain occasions methemoglobin can lead to falsely normal SpO 2 readings, despite a low SaO 2 (12) . The source of error caused by these two dyshemoglobins can be mitigated by using co-oximetry, which requires an ABG.
Most studies investigating agreement between SpO 2 and SaO 2 have concentrated on critically ill inpatient populations (3, 13) , and studies in healthier, outpatient cohorts both at rest and during exercise are lacking. The purpose of our study is to examine the degree of discrepancy between SpO 2 and SaO 2 both at rest and at maximum exercise and identify parameters that may explain this difference. We hypothesize that the discrepancy between SpO 2 and SaO 2 increases at maximal exercise and that several factors (particularly carboxyhemoglobin) can explain this difference. To test our hypothesis, we retrospectively examined a cohort of patients undergoing cardiopulmonary exercise testing (CPET) at our institution, compared SpO 2 with SaO 2 both at baseline and at peak exercise during CPET, and tested whether variables collected during CPET can explain the differences between SpO 2 and SaO 2 .
METHODS
Study population. The study was approved by the institutional review board of the Cleveland Clinic (IRB 15-1288). Data from 751 patients referred for CPET at the Respiratory Institute of the Cleveland Clinic, from January 2010 to January 2015, were retrospectively analyzed. Informed consent was waived.
Pulse oximetry and arterial oxygenation determinations. Our CPET protocol included the use of pulse oximeters (Nonin Avant 4000 system; Nonin, Plymouth, MI) with forehead probes to measure SpO 2 both at baseline and during exercise. We routinely placed two pulse oximetry probes on the forehead to test accuracy and only recorded the most reliable determination based on the quality of the SpO 2 waveform. Forehead oximetry probes were held in place by an elastic band. Respiratory therapists recorded the SpO 2 measurement only when the waveform had a dicrotic notch and was synchronized with the heart rate observed in the electrocardiographic monitoring (14) . SpO 2 at the time of ABG acquisition was recorded both at rest and peak exercise to avoid temporal variations. Measurements at rest were done in a sitting position after the patient relaxed for at least 10 min.
As part of our CPET protocol, SaO 2 levels were obtained from ABG samples taken from individual punctures of the radial artery (usually the left one) while patients sat on the bicycle. We did not place an arterial catheter. The ABG determinations were performed with co-oximetry using the ABL800 FLEX Blood Gas Analyzer (Radiometer, BrLnshLj, Denmark). ABG determinations were reported at 37-C without correction by the core body temperature. Both SpO 2 and SaO 2 determinations were taken at rest (before exercise) and at maximum exercise (during the last 1-2 min, just before stopping). Reasons for not being able to obtain an ABG at maximum exercise include the following: more than two unsuccessful attempts, transition into the recovery phase, and gasometric findings indicative of venous blood. In every patient, we recorded the amount of oxygen supplementation administered at the time of the measurements. If the patient required any degree of oxygen supplementation, either at rest or during activities, the CPET (including baseline and exercise determinations) was done with a fraction of inspired oxygen (FiO 2 ) of 30% using a bag reservoir.
Cardiopulmonary exercise testing protocol. Cardiopulmonary exercise testing was ordered by pulmonary physicians based on established indications and done on an electrically braked cycle ergometer following recommendations by the American Thoracic Society and American College of Chest Physicians (15) . Electrodes were placed on the skin to be able to obtain a 12-lead electrocardiogram. Blood pressure was recorded using a cuff placed on the arm opposite to the ABG site. An appropriate face mask (7450 SeriesV2 Mask; Hans Rudolph, Shawnee, KS) size was selected and a good seal was verified. Measurements were obtained with the MedGraphics Ultima system (MGC Diagnostics, Saint Paul, MN, USA) following the manufacturer_s recommendations. We used different maximal incremental exercise testing protocols based on the evaluation of each patient and with the intention of adjusting the exercise duration to approximately 8 to 12 min. Tests were terminated when the patient reached exhaustion (defined as 10/10 on the Borg scale or the inability to maintain pedal speed) or developed pronounced dizziness, leg, knee, chest, or back pain (15) .
For our study, we recorded the following CPET variables: work rate, oxygen uptake (V O 2 ), carbon dioxide output (V CO 2 ), respiratory exchange ratio, anaerobic threshold, tidal volume, respiratory rate, minute ventilation (V E ), V E /V CO 2 , V E /V O 2 , breathing reserve, end-tidal PCO 2 , heart rate, heart rate reserve, blood pressure, oxygen pulse, exercise duration, and reasons for stopping the test. We also recorded SpO 2 and SaO 2 as well as other ABG results (PaO 2 , alveolar-arterial difference for oxygen pressure, partial pressure of carbon dioxide (PaCO 2 ), pH, bicarbonate, lactate, hemoglobin, and carboxyhemoglobin), maximum voluntary ventilation measured at baseline, and forced expiratory volume in the first second (FEV1), forced vital capacity (FVC), and FEV1/FVC (16) both at baseline and immediately after exercise.
Other variables. We collected data on age, gender, height, weight, smoking status, type of CPET protocol (5 to 30 WImin j1 ), and reasons for the test. Reasons for ordering CPET were clustered in four groups including (a) unexplained dyspnea, (b) preoperative work-up for cardiovascular or lung surgeries, (c) diagnose or evaluate treatment response in exerciseinduced asthma, and (d) others. In addition, we reviewed the patient_s medications, time and contents of the last meal.
Statistical analysis. Descriptive statistics (mean T SD, median (interquartile range), or n (%)) were used to summarize demographic and clinically relevant variables. Continuous variables were compared with t test. Categorical variables were tested using W 2 or Fisher_s exact test, when appropriate. Univariate linear regression was used to examine whether certain variables of interest eloquent were associated with the difference between SpO 2 and SaO 2 both at rest and peak exertion. Multivariate analysis was subsequently performed to examine the association between variables that achieved a P value G 0.10 in the univariate analysis. Variables in the models were tested for multicollinearity using variance inflation factors and removing variables with a value larger than 4. Bland-Altman analysis was used to display the degree of bias and limits of agreement between SpO 2 and SaO 2 both at rest and peak exertion, using SaO 2 as the gold standard in the x axis. We compared the patient characteristics at rest and during exercise between subjects that showed a difference between SpO 2 and SaO 2 G 5% or 9 = 5%. This prespecified but arbitrary cutoff was chosen to reflect an eloquent difference between measurements. Statistical significance was defined as a P value less than 0.05. All analyses were performed using R: a Language and Environment for Statistical Computing (version 3.3.0).
RESULTS
Patient demographics. The mean age of the cohort (n = 751) was 54.1 T 16.1 yr. A total of 355 (47%) patients were male. The majority of the tests were ordered for unexplained dyspnea (n = 558 [74.3%]). Table 1 presents the baseline characteristics of the patients.
Oximetry at baseline. Results of the ABG analysis, spirometry, and CPET at baseline are shown in Table 2 . The baseline SpO 2 was 98.2% T 1.8%. The test was done on room air in 735 (97.9%) patients and on gas with 30% FiO 2 in the rest (n = 16 [2.1%]). The SpO 2 in individuals on room air and FiO 2 30% was 98.2% T 1.8% and 98.3% T 1.3%, respectively. Meanwhile, the SaO 2 was 94.4% T 1.7% and 95.2% T 1.3% for those breathing room air and FiO 2 of 30%, respectively. At rest, Bland-Altman analysis comparing SpO 2 with SaO 2 (gold standard) demonstrated a bias of 3.8% with limits of agreement of j0.3% to 7.9% (Fig. 1, panel A) . The vast majority (96.8%) of SpO 2 values were higher than the SaO 2 determinations, and it appears that the lower the SaO 2 , the more pronounced the gap with SpO 2 (Fig. 1, panel A) .
To better identify the characteristics associated with a larger difference between SpO 2 and SaO 2 at rest, we compared patients in whom the SpO 2 was Q5% points higher than the SaO 2 (n = 174, 23%) versus those with G5% points difference (n = 577 [77%]) ( Table 3) . We noted that when the difference between SpO 2 and SaO 2 was Q 5%, patients were older, with a higher proportion of current smokers, higher carboxyhemoglobin and PaCO 2 and lower FEV1, end-tidal CO 2 , and hemoglobin (Table 3) .
In a multivariate analysis, we noted that the variables that were independently associated with the difference between Oximetry at peak exercise. In 120 (16%) patients, ABG was obtained at baseline but could not be obtained at peak exercise, therefore, at total 631 (84%) patients had both ABG and SpO 2 at peak exercise. Seventy-eight (12.4%) patients had a SpO 2 Q 5% points than the SaO 2 . BlandAltman analysis showed a bias of 2.6% with limits of agreement of j2.9% and 8.1% (Fig. 1 panel B) . Interestingly, at peak exercise, several SpO 2 values (n = 75, 11.9%) were lower than the SaO 2 determinations. At peak exercise, a SpO 2 Q 5% point higher than the SaO 2 was associated with older age, lower height and weight, current smoker status, higher PaCO 2 , bicarbonate, and carboxyhemoglobin, lower hemoglobin, FVC, FEV1, maximum heart rate, oxygen consumption, and O 2 pulse (Table 4 ). In multivariate analysis, the variables independently associated with the difference between SpO 2 and SaO 2 at peak exercise were lower FVC (per 1 L change, A = j0.27, P = 0.001) and higher carboxyhemoglobin (per 1% change, A = 0.78, P G 0.001). http://www.acsm-msse.org A decrease in SaO 2 Q 4% during exercise is commonly considered clinically significant (15) . At total of 26 (4%) patients had a decrease in SaO 2 Q 4% at maximum exercise and of them 20 (77%) had a drop in SpO 2 Q 4%. A drop in SpO 2 Q 4% had false positive and negative rates of 10% and 1%, respectively, for detecting a decrease in SaO 2 of Q 4%.
DISCUSSION
The present study improves the understanding of the magnitude, direction, and potential sources of error of pulse oximetry during exercise. It validates that carboxyhemoglobin is an important factor in explaining the difference between SpO 2 and SaO 2 and supports obtaining ABG determinations in certain patients, particularly current smokers. In addition, we noted that a small proportion of patients had a falsely low SpO 2 reading during exercise that if not confirmed by ABG may lead to unnecessary testing.
The importance of pulse oximetry as a rapid, noninvasive tool to assess oxygenation cannot be understated. However, this methodology is susceptible to measuring error due to a variety of conditions. In general, the margin of error of SpO 2 is within 2% to 3% of the SaO 2 (13, 17, 18) . Taking advantage of the large number of data collected and investigations performed at the time of CPET in our institution, we sought to test the accuracy of SpO 2 to estimate SaO 2 both at rest and at peak exercise with a particular focus in identifying factors accounting for the discrepancy between measurements.
In our laboratory and using the equipment described, we found that the bias between SpO 2 and SaO 2 did not increase during exercise (3.8% at baseline and 2.6% during the exercise), with the majority of the SpO 2 determinations overestimating SaO 2 , particularly when the SaO 2 was below 90% or patients were current smokers. At peak exercise, the limit of agreement between SpO 2 and SaO 2 widened by one third from a gap of 8.25% to 10.99%, with more determinations in which SpO 2 was lower than SaO 2 , reflecting limitations in the accurate determination of SpO 2 , particularly during exercise. We identified several patient_s characteristics associated with Q5% points higher SpO 2 compared with SaO 2 , such as older age, current smoker status, lower FEV1, and higher PaCO 2 and carboxyhemoglobin. In addition, during peak exercise, patients FIGURE 1-Bland-Altman plots testing the differences between SpO 2 and SaO 2 at rest and peak exercise. Plots show the mean difference and 95% confidence interval between SpO 2 and SaO 2 , labeled by smoking status (current smoker, ex-smoker, and never smokers). Panel A: determinations at rest. Panel B: determinations at peak exercise. with a larger gap between SpO 2 and SaO 2 had lower heart rate, lower oxygen consumption, and oxygen pulse. A few studies that included a small number of healthy patients tested the validity of pulse oximetry during maximal exercise and noted an underestimation (14, 19) or overestimation (20, 21) of the SaO 2 , with some suggesting a better precision when using a forehead sensor (14) . To our knowledge, our study is the first to investigate the inconsistencies between SpO 2 measured with a forehead probe and SaO 2 in an outpatient cohort both at rest and peak exercise. The majority of our patients underwent CPET for unexplained dyspnea or as part of preoperative work-up. Other studies have examined the discordance between SpO 2 and SaO 2 ; however, these cohorts consisted of critically ill inpatients or patients who recently underwent surgery (3, 7, 13, (22) (23) (24) . Similar to these other investigations we noted that the bias between SpO 2 and SaO 2 at rest was 3.8%.
Motion artifact is one of the major causes of inaccurate pulse oximetry readings. We used a forehead probe to reduce the possibility of motion artifact and errors caused as a result of gripping the bicycle handlebars (14) . We paid particular attention to the quality of SpO 2 waveform and test its accuracy against a second forehead probe. An accurate determination of SpO 2 is critical, since desaturations during CPET can lead to further invasive testing and expense. Although at rest we noted that SpO 2 systematically overestimates SaO 2 , at peak exercise we observed that 10 (1.6%) patients had an SpO 2 below the SaO 2 , in a range that could be considered hypoxemia (SpO 2 G 90%). In addition, in 10% of the patients we noted a drop in SaO 2 Q 4% during maximal exercise, at odds with the corresponding changes in SaO 2 . These discrepancies could be related to forehead hypoperfusion, venous congestion with venous pulsations (25) , or inaccuracies in the SpO 2 determination due to head motion during the activity. Given these findings and the additional information provided by the test, we recommend obtaining an ABG both at baseline and particularly at peak exercise during CPET (unless contraindicated) either using repeated punctures or an arterial line. The ABG collection adds discomfort and an extra expense to patients. In addition, the ABG needs to be obtained at maximum exercise, since values can rapidly change in the recovery phase. Taking these caveats into consideration, we believe in confirming unexpected SpO 2 values with ABG analysis, particularly during exercise.
One of the main factors involved in the falsely high SpO 2 readings is carboxyhemoglobin (12) , which absorbs light at approximately the same spectrum as oxyhemoglobin. Therefore, the determination presented by the pulse oximeter is a summation of oxyhemoglobin plus carboxyhemoglobin. This is particularly relevant in smokers, as noted in our analyses, and may explain the association with lower FEV1 and higher PaCO 2 . In our cohort, carboxyhemoglobin was an important factor, however, it explained less than half of the difference between SpO 2 and SaO 2 . Cooximetry, which measures light absorbance at multiple wave lengths, is certainly needed if this source of error is suspected. In addition, data obtained at rest showed that PaO 2 and hemoglobin were inversely associated with the difference between SpO 2 and SaO 2 ; variables that may impact the accuracy of the pulse oximetry.
Our study is not without limitations: (a) in 120 (16%) patients we could not obtain peak exercise ABG; (b) pulse oximetry results were obtained with a forehead probe to minimize motion artifact (26) , it is unclear if our findings can be extrapolated to finger probes; (c) SpO 2 readings may vary according to the model of pulse oximeter used (12, 14, 27) ; and (d) race was not recorded.
CONCLUSIONS
In the present study, pulse oximetry commonly overestimated the arterial oxygen saturation. Increased carboxyhemoglobin levels are major contributors to the difference between arterial and pulse oxygen saturation both at rest and peak exercise, a finding particularly relevant in smokers. 
